+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunochemistry Market In Americas 2026-2030

  • PDF Icon

    Report

  • 224 Pages
  • September 2026
  • Region: Latin America, North America
  • TechNavio
  • ID: 5980920
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunochemistry market in americas is forecasted to grow by USD 4.13 billion during 2025-2030, accelerating at a CAGR of 7.0% during the forecast period. The report on the immunochemistry market in americas provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing burden of chronic and infectious diseases, expansion of precision medicine and biomarker-based healthcare, increasing investment in healthcare infrastructure and diagnostic services.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The immunochemistry market in americas is segmented as below:

By Application

  • Infectious disease
  • Cardiology
  • Oncology
  • Autoimmune disease
  • Others

By Product

  • Consumables
  • Equipment

By End-User

  • Hospital and diagnostics center
  • Academic and research institutions
  • CROs

Geography

  • Americas
This study identifies the growing adoption of multiplex testing platforms as one of the prime reasons driving the immunochemistry market in americas growth during the next few years. Also, integration of digital pathology and connected laboratory ecosystems and expansion of decentralized and near-patient diagnostic models will lead to sizable demand in the market.

The report on the immunochemistry market in americas covers the following areas:

  • Immunochemistry market in americas sizing
  • Immunochemistry market in americas forecast
  • Immunochemistry market in americas industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunochemistry market in americas vendors that include Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, DiaSorin SpA, F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Grifols SA, Meso Scale Diagnostics LLC, Quanterix Corp., QuidelOrtho Corp., Randox Laboratories Ltd., Revvity Inc., Shenzhen Mindray Co. Ltd., Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., Werfenlife SA. Also, the immunochemistry market in americas analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Country Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
  • Overview on factors of disruption
2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
  • Chart on Parent Market
  • Data Table on - Parent Market
3.2 Market characteristics
  • Chart on Market characteristics analysis
3.3 Value chain analysis
  • Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
  • Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
  • Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
  • Chart on Americas - Market size and forecast 2025-2030 ($ million)
  • Data Table on Regional - Market size and forecast 2025-2030 ($ million)
  • Chart on Americas: Year-over-year growth 2025-2030 (%)
  • Data Table on Regional - Market size and forecast 2025-2030 ($ million)
5 Historic Market Size
5.1 Immunochemistry Market in Americas 2020 - 2024
  • Historic Market Size - Data Table on Immunochemistry Market in Americas 2020 - 2024 ($ million)
5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
5.3 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on immunochemistry market in Americas
6.2 Impact of geopolitical conflicts on immunochemistry market in Americas
7 Five Forces Analysis
7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
  • Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Application
8.1 Market segments
  • Chart on Application - Market share 2025-2030 (%)
  • Data Table on Application - Market share 2025-2030 (%)
8.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
8.3 Infectious disease - Market size and forecast 2025-2030
  • Chart on Infectious disease - Market size and forecast 2025-2030 ($ million)
  • Data Table on Infectious disease - Market size and forecast 2025-2030 ($ million)
  • Chart on Infectious disease - Year-over-year growth 2025-2030 (%)
  • Data Table on Infectious disease - Year-over-year growth 2025-2030 (%)
8.4 Cardiology - Market size and forecast 2025-2030
  • Chart on Cardiology - Market size and forecast 2025-2030 ($ million)
  • Data Table on Cardiology - Market size and forecast 2025-2030 ($ million)
  • Chart on Cardiology - Year-over-year growth 2025-2030 (%)
  • Data Table on Cardiology - Year-over-year growth 2025-2030 (%)
8.5 Oncology - Market size and forecast 2025-2030
  • Chart on Oncology - Market size and forecast 2025-2030 ($ million)
  • Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
  • Chart on Oncology - Year-over-year growth 2025-2030 (%)
  • Data Table on Oncology - Year-over-year growth 2025-2030 (%)
8.6 Autoimmune disease - Market size and forecast 2025-2030
  • Chart on Autoimmune disease - Market size and forecast 2025-2030 ($ million)
  • Data Table on Autoimmune disease - Market size and forecast 2025-2030 ($ million)
  • Chart on Autoimmune disease - Year-over-year growth 2025-2030 (%)
  • Data Table on Autoimmune disease - Year-over-year growth 2025-2030 (%)
8.7 Others - Market size and forecast 2025-2030
  • Chart on Others - Market size and forecast 2025-2030 ($ million)
  • Data Table on Others - Market size and forecast 2025-2030 ($ million)
  • Chart on Others - Year-over-year growth 2025-2030 (%)
  • Data Table on Others - Year-over-year growth 2025-2030 (%)
8.8 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by Product
9.1 Market segments
  • Chart on Product - Market share 2025-2030 (%)
  • Data Table on Product - Market share 2025-2030 (%)
9.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
9.3 Consumables - Market size and forecast 2025-2030
  • Chart on Consumables - Market size and forecast 2025-2030 ($ million)
  • Data Table on Consumables - Market size and forecast 2025-2030 ($ million)
  • Chart on Consumables - Year-over-year growth 2025-2030 (%)
  • Data Table on Consumables - Year-over-year growth 2025-2030 (%)
9.4 Equipment - Market size and forecast 2025-2030
  • Chart on Equipment - Market size and forecast 2025-2030 ($ million)
  • Data Table on Equipment - Market size and forecast 2025-2030 ($ million)
  • Chart on Equipment - Year-over-year growth 2025-2030 (%)
  • Data Table on Equipment - Year-over-year growth 2025-2030 (%)
9.5 Market opportunity by Product
  • Market opportunity by Product ($ million)
  • Data Table on Market opportunity by Product ($ million)
10 Market Segmentation by End-user
10.1 Market segments
  • Chart on End-user - Market share 2025-2030 (%)
  • Data Table on End-user - Market share 2025-2030 (%)
10.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
10.3 Hospital and diagnostics center - Market size and forecast 2025-2030
  • Chart on Hospital and diagnostics center - Market size and forecast 2025-2030 ($ million)
  • Data Table on Hospital and diagnostics center - Market size and forecast 2025-2030 ($ million)
  • Chart on Hospital and diagnostics center - Year-over-year growth 2025-2030 (%)
  • Data Table on Hospital and diagnostics center - Year-over-year growth 2025-2030 (%)
10.4 Academic and research institutions - Market size and forecast 2025-2030
  • Chart on Academic and research institutions - Market size and forecast 2025-2030 ($ million)
  • Data Table on Academic and research institutions - Market size and forecast 2025-2030 ($ million)
  • Chart on Academic and research institutions - Year-over-year growth 2025-2030 (%)
  • Data Table on Academic and research institutions - Year-over-year growth 2025-2030 (%)
10.5 CROs - Market size and forecast 2025-2030
  • Chart on CROs - Market size and forecast 2025-2030 ($ million)
  • Data Table on CROs - Market size and forecast 2025-2030 ($ million)
  • Chart on CROs - Year-over-year growth 2025-2030 (%)
  • Data Table on CROs - Year-over-year growth 2025-2030 (%)
10.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape
11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
  • Chart on Market share by geography - 2025-2030 (%)
  • Data Table on Market share by geography - 2025-2030 (%)
12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
12.3 US - Market size and forecast 2025-2030
  • Chart on US - Market size and forecast 2025-2030 ($ million)
  • Data Table on US - Market size and forecast 2025-2030 ($ million)
  • Chart on US - Year-over-year growth 2025-2030 (%)
  • Data Table on US - Year-over-year growth 2025-2030 (%)
12.4 Canada - Market size and forecast 2025-2030
  • Chart on Canada - Market size and forecast 2025-2030 ($ million)
  • Data Table on Canada - Market size and forecast 2025-2030 ($ million)
  • Chart on Canada - Year-over-year growth 2025-2030 (%)
  • Data Table on Canada - Year-over-year growth 2025-2030 (%)
12.5 Brazil - Market size and forecast 2025-2030
  • Chart on Brazil - Market size and forecast 2025-2030 ($ million)
  • Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
  • Chart on Brazil - Year-over-year growth 2025-2030 (%)
  • Data Table on Brazil - Year-over-year growth 2025-2030 (%)
12.6 Mexico - Market size and forecast 2025-2030
  • Chart on Mexico - Market size and forecast 2025-2030 ($ million)
  • Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
  • Chart on Mexico - Year-over-year growth 2025-2030 (%)
  • Data Table on Mexico - Year-over-year growth 2025-2030 (%)
12.7 Rest of Americas - Market size and forecast 2025-2030
  • Chart on Rest of Americas - Market size and forecast 2025-2030 ($ million)
  • Data Table on Rest of Americas - Market size and forecast 2025-2030 ($ million)
  • Chart on Rest of Americas - Year-over-year growth 2025-2030 (%)
  • Data Table on Rest of Americas - Year-over-year growth 2025-2030 (%)
12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Table on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
  • Growing burden of chronic and infectious diseases
  • Expansion of precision medicine and biomarker-based healthcare
  • Increasing investment in healthcare infrastructure and diagnostic services
13.2 Market challenges
  • High cost of advanced diagnostic infrastructure
  • Complex regulatory and compliance requirements
  • Shortage of specialized laboratory professionals
13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
  • Growing adoption of multiplex testing platforms
  • Integration of digital pathology and connected laboratory ecosystems
  • Expansion of decentralized and near-patient diagnostic models
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
  • Overview on factors of disruption
14.4 Industry risks
  • Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
  • Companies covered
15.2 Company ranking index
  • Company ranking index
15.3 Market positioning of companies
  • Matrix on companies position and classification
15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
15.5 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
15.6 Beckman Coulter Inc.
  • Beckman Coulter Inc. - Overview
  • Beckman Coulter Inc. - Product / Service
  • Beckman Coulter Inc. - Key offerings
  • SWOT
15.7 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
15.8 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
15.9 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
15.10 DiaSorin SpA
  • DiaSorin SpA - Overview
  • DiaSorin SpA - Business segments
  • DiaSorin SpA - Key news
  • DiaSorin SpA - Key offerings
  • DiaSorin SpA - Segment focus
  • SWOT
15.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
15.12 Grifols SA
  • Grifols SA - Overview
  • Grifols SA - Business segments
  • Grifols SA - Key offerings
  • Grifols SA - Segment focus
  • SWOT
15.13 QuidelOrtho Corp.
  • QuidelOrtho Corp. - Overview
  • QuidelOrtho Corp. - Business segments
  • QuidelOrtho Corp. - Key offerings
  • QuidelOrtho Corp. - Segment focus
  • SWOT
15.14 Revvity Inc.
  • Revvity Inc. - Overview
  • Revvity Inc. - Business segments
  • Revvity Inc. - Key offerings
  • Revvity Inc. - Segment focus
  • SWOT
15.15 Shenzhen Mindray Co. Ltd.
  • Shenzhen Mindray Co. Ltd. - Overview
  • Shenzhen Mindray Co. Ltd. - Business segments
  • Shenzhen Mindray Co. Ltd. - Key offerings
  • Shenzhen Mindray Co. Ltd. - Segment focus
  • SWOT
15.16 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
15.17 Sysmex Corp.
  • Sysmex Corp. - Overview
  • Sysmex Corp. - Business segments
  • Sysmex Corp. - Key offerings
  • Sysmex Corp. - Segment focus
  • SWOT
15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
16 Appendix
16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
16.4 Research methodology
  • Research methodology
16.5 Data procurement
  • Information sources
16.6 Data validation
  • Data validation
16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
16.8 Data synthesis
  • Data synthesis
16.9 360 degree market analysis
  • 360 degree market analysis
16.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Country Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Application
Exhibit 6: Executive Summary - Chart on Market Segmentation by Product
Exhibit 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Overview on criticality of inputs and factors of differentiation
Exhibit 13: Overview on factors of disruption
Exhibit 14: Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Americas - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Regional - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Americas: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Regional - Market size and forecast 2025-2030 ($ million)
Exhibit 25: Historic Market Size - Data Table on Immunochemistry Market in Americas 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Five forces analysis - Comparison between 2025 and 2030
Exhibit 31: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 32: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 33: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 36: Chart on Market condition - Five forces 2025 and 2030
Exhibit 37: Chart on Application - Market share 2025-2030 (%)
Exhibit 38: Data Table on Application - Market share 2025-2030 (%)
Exhibit 39: Chart on Comparison by Application
Exhibit 40: Data Table on Comparison by Application
Exhibit 41: Chart on Infectious disease - Market size and forecast 2025-2030 ($ million)
Exhibit 42: Data Table on Infectious disease - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Chart on Infectious disease - Year-over-year growth 2025-2030 (%)
Exhibit 44: Data Table on Infectious disease - Year-over-year growth 2025-2030 (%)
Exhibit 45: Chart on Cardiology - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Data Table on Cardiology - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Chart on Cardiology - Year-over-year growth 2025-2030 (%)
Exhibit 48: Data Table on Cardiology - Year-over-year growth 2025-2030 (%)
Exhibit 49: Chart on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Chart on Oncology - Year-over-year growth 2025-2030 (%)
Exhibit 52: Data Table on Oncology - Year-over-year growth 2025-2030 (%)
Exhibit 53: Chart on Autoimmune disease - Market size and forecast 2025-2030 ($ million)
Exhibit 54: Data Table on Autoimmune disease - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Chart on Autoimmune disease - Year-over-year growth 2025-2030 (%)
Exhibit 56: Data Table on Autoimmune disease - Year-over-year growth 2025-2030 (%)
Exhibit 57: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 60: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 61: Market opportunity by Application ($ million)
Exhibit 62: Data Table on Market opportunity by Application ($ million)
Exhibit 63: Chart on Product - Market share 2025-2030 (%)
Exhibit 64: Data Table on Product - Market share 2025-2030 (%)
Exhibit 65: Chart on Comparison by Product
Exhibit 66: Data Table on Comparison by Product
Exhibit 67: Chart on Consumables - Market size and forecast 2025-2030 ($ million)
Exhibit 68: Data Table on Consumables - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Chart on Consumables - Year-over-year growth 2025-2030 (%)
Exhibit 70: Data Table on Consumables - Year-over-year growth 2025-2030 (%)
Exhibit 71: Chart on Equipment - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Data Table on Equipment - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Chart on Equipment - Year-over-year growth 2025-2030 (%)
Exhibit 74: Data Table on Equipment - Year-over-year growth 2025-2030 (%)
Exhibit 75: Market opportunity by Product ($ million)
Exhibit 76: Data Table on Market opportunity by Product ($ million)
Exhibit 77: Chart on End-user - Market share 2025-2030 (%)
Exhibit 78: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 79: Chart on Comparison by End-user
Exhibit 80: Data Table on Comparison by End-user
Exhibit 81: Chart on Hospital and diagnostics center - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Data Table on Hospital and diagnostics center - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Chart on Hospital and diagnostics center - Year-over-year growth 2025-2030 (%)
Exhibit 84: Data Table on Hospital and diagnostics center - Year-over-year growth 2025-2030 (%)
Exhibit 85: Chart on Academic and research institutions - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Data Table on Academic and research institutions - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Chart on Academic and research institutions - Year-over-year growth 2025-2030 (%)
Exhibit 88: Data Table on Academic and research institutions - Year-over-year growth 2025-2030 (%)
Exhibit 89: Chart on CROs - Market size and forecast 2025-2030 ($ million)
Exhibit 90: Data Table on CROs - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Chart on CROs - Year-over-year growth 2025-2030 (%)
Exhibit 92: Data Table on CROs - Year-over-year growth 2025-2030 (%)
Exhibit 93: Market opportunity by End-user ($ million)
Exhibit 94: Data Table on Market opportunity by End-user ($ million)
Exhibit 95: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 96: Chart on Market share by geography - 2025-2030 (%)
Exhibit 97: Data Table on Market share by geography - 2025-2030 (%)
Exhibit 98: Chart on Geographic comparison
Exhibit 99: Data Table on Geographic comparison
Exhibit 100: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 103: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 104: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 107: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 108: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 110: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 111: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 112: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 115: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 116: Chart on Rest of Americas - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Data Table on Rest of Americas - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Chart on Rest of Americas - Year-over-year growth 2025-2030 (%)
Exhibit 119: Data Table on Rest of Americas - Year-over-year growth 2025-2030 (%)
Exhibit 120: Market opportunity by geography ($ million)
Exhibit 121: Data Table on Market opportunity by geography ($ million)
Exhibit 122: Impact of drivers and challenges in 2025 and 2030
Exhibit 123: Overview on criticality of inputs and factors of differentiation
Exhibit 124: Overview on factors of disruption
Exhibit 125: Impact of key risks on business
Exhibit 126: Companies covered
Exhibit 127: Company ranking index
Exhibit 128: Matrix on companies position and classification
Exhibit 129: Abbott Laboratories - Overview
Exhibit 130: Abbott Laboratories - Business segments
Exhibit 131: Abbott Laboratories - Key news
Exhibit 132: Abbott Laboratories - Key offerings
Exhibit 133: Abbott Laboratories - Segment focus
Exhibit 134: SWOT
Exhibit 135: Agilent Technologies Inc. - Overview
Exhibit 136: Agilent Technologies Inc. - Business segments
Exhibit 137: Agilent Technologies Inc. - Key news
Exhibit 138: Agilent Technologies Inc. - Key offerings
Exhibit 139: Agilent Technologies Inc. - Segment focus
Exhibit 140: SWOT
Exhibit 141: Beckman Coulter Inc. - Overview
Exhibit 142: Beckman Coulter Inc. - Product / Service
Exhibit 143: Beckman Coulter Inc. - Key offerings
Exhibit 144: SWOT
Exhibit 145: Becton Dickinson and Co. - Overview
Exhibit 146: Becton Dickinson and Co. - Business segments
Exhibit 147: Becton Dickinson and Co. - Key news
Exhibit 148: Becton Dickinson and Co. - Key offerings
Exhibit 149: Becton Dickinson and Co. - Segment focus
Exhibit 150: SWOT
Exhibit 151: Bio Rad Laboratories Inc. - Overview
Exhibit 152: Bio Rad Laboratories Inc. - Business segments
Exhibit 153: Bio Rad Laboratories Inc. - Key news
Exhibit 154: Bio Rad Laboratories Inc. - Key offerings
Exhibit 155: Bio Rad Laboratories Inc. - Segment focus
Exhibit 156: SWOT
Exhibit 157: BioMerieux SA - Overview
Exhibit 158: BioMerieux SA - Business segments
Exhibit 159: BioMerieux SA - Key offerings
Exhibit 160: BioMerieux SA - Segment focus
Exhibit 161: SWOT
Exhibit 162: DiaSorin SpA - Overview
Exhibit 163: DiaSorin SpA - Business segments
Exhibit 164: DiaSorin SpA - Key news
Exhibit 165: DiaSorin SpA - Key offerings
Exhibit 166: DiaSorin SpA - Segment focus
Exhibit 167: SWOT
Exhibit 168: F. Hoffmann La Roche Ltd. - Overview
Exhibit 169: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 170: F. Hoffmann La Roche Ltd. - Key news
Exhibit 171: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 172: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 173: SWOT
Exhibit 174: Grifols SA - Overview
Exhibit 175: Grifols SA - Business segments
Exhibit 176: Grifols SA - Key offerings
Exhibit 177: Grifols SA - Segment focus
Exhibit 178: SWOT
Exhibit 179: QuidelOrtho Corp. - Overview
Exhibit 180: QuidelOrtho Corp. - Business segments
Exhibit 181: QuidelOrtho Corp. - Key offerings
Exhibit 182: QuidelOrtho Corp. - Segment focus
Exhibit 183: SWOT
Exhibit 184: Revvity Inc. - Overview
Exhibit 185: Revvity Inc. - Business segments
Exhibit 186: Revvity Inc. - Key offerings
Exhibit 187: Revvity Inc. - Segment focus
Exhibit 188: SWOT
Exhibit 189: Shenzhen Mindray Co. Ltd. - Overview
Exhibit 190: Shenzhen Mindray Co. Ltd. - Business segments
Exhibit 191: Shenzhen Mindray Co. Ltd. - Key offerings
Exhibit 192: Shenzhen Mindray Co. Ltd. - Segment focus
Exhibit 193: SWOT
Exhibit 194: Siemens Healthineers AG - Overview
Exhibit 195: Siemens Healthineers AG - Business segments
Exhibit 196: Siemens Healthineers AG - Key offerings
Exhibit 197: Siemens Healthineers AG - Segment focus
Exhibit 198: SWOT
Exhibit 199: Sysmex Corp. - Overview
Exhibit 200: Sysmex Corp. - Business segments
Exhibit 201: Sysmex Corp. - Key offerings
Exhibit 202: Sysmex Corp. - Segment focus
Exhibit 203: SWOT
Exhibit 204: Thermo Fisher Scientific Inc. - Overview
Exhibit 205: Thermo Fisher Scientific Inc. - Business segments
Exhibit 206: Thermo Fisher Scientific Inc. - Key news
Exhibit 207: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 208: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 209: SWOT
Exhibit 210: Inclusions checklist
Exhibit 211: Exclusions checklist
Exhibit 212: Currency conversion rates for US$
Exhibit 213: Research methodology
Exhibit 214: Information sources
Exhibit 215: Data validation
Exhibit 216: Validation techniques employed for market sizing
Exhibit 217: Data synthesis
Exhibit 218: 360 degree market analysis
Exhibit 219: List of abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Beckman Coulter Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • BioMerieux SA
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Fujirebio Holdings Inc.
  • Grifols SA
  • Meso Scale Diagnostics LLC
  • Quanterix Corp.
  • QuidelOrtho Corp.
  • Randox Laboratories Ltd.
  • Revvity Inc.
  • Shenzhen Mindray Co. Ltd.
  • Siemens Healthineers AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Werfenlife SA